Formation of invadopodia-like structures by synovial cells promotes cartilage breakdown in collagen-induced arthritis: Involvement of the protein tyrosine kinase Src

Arthritis and Rheumatism

Volumn 63, Issue 6, 2011, Pages 1591-1602

  Lauzier, Annie ^a   Charbonneau, Martine ^a   Harper, Kelly ^a   Jilaveanu Pelmus, Manuela ^a   Dubois, Claire M ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COLLAGEN; PROTEIN TYROSINE KINASE; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BONE DESTRUCTION; CARTILAGE DEGENERATION; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HYPERPLASIA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNOVIOCYTE; WILD TYPE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE; CELL SURFACE EXTENSIONS; CELLS, CULTURED; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RATS; RATS, INBRED LEW; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; SYNOVIAL FLUID;

EID: 79958022115     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30305     Document Type: Article

References (50)

1. Muller-Ladner U, Ospelt C, Gay S, Distler O, Pap T,. Cells of the synovium in rheumatoid arthritis: synovial fibroblasts. Arthritis Res Ther 2007; 9: 223.
2. Rengel Y, Ospelt C, Gay S,. Proteinases in the joint: clinical relevance of proteinases in joint destruction. Arthritis Res Ther 2007; 9: 221.
3. Goldring SR,. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford) 2003; 42 Suppl 2: ii11-6. (Pubitemid 37220895)
4. Fiedorczyk M, Klimiuk PA, Sierakowski S, Gindzienska-Sieskiewicz E, Chwiecko J,. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. J Rheumatol 2006; 33: 1523-9. (Pubitemid 44168822)
5. Konttinen YT, Salo T, Hanemaaijer R, Valleala H, Sorsa T, Sutinen M, et al. Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol 1999; 18: 401-12. (Pubitemid 29397452)
6. Nagase H,. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997; 378: 151-60. (Pubitemid 27230597)
7. Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG, et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 2002; 61: 975-80. (Pubitemid 35221685)
8. Miller MC, Manning HB, Jain A, Troeberg L, Dudhia J, Essex D, et al. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. Arthritis Rheum 2009; 60: 686-97.
9. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996; 149: 1607-15. (Pubitemid 26363967)
10. Lehmann J, Jungel A, Lehmann I, Busse F, Biskop M, Saalbach A, et al. Grafting of fibroblasts isolated from the synovial membrane of rheumatoid arthritis (RA) patients induces chronic arthritis in SCID mice-a novel model for studying the arthritogenic role of RA fibroblasts in vivo. J Autoimmun 2000; 15: 301-13.
11. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL,. Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-β and retinoids. J Clin Invest 1989; 83: 1267-76. (Pubitemid 19113041)
12. Imamura F, Aono H, Hasunuma T, Sumida T, Tateishi H, Maruo S, et al. Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1979-86. (Pubitemid 28506688)
13. Muller-Ladner U, Kriegsmann J, Gay RE, Gay S,. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995; 21: 675-90.
14. Chen WT,. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J Exp Zool 1989; 251: 167-85.
15. Weaver AM,. Invadopodia. Curr Biol 2008; 18: R362-4. (Pubitemid 351626587)
16. Mueller SC, Yeh Y, Chen WT,. Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J Cell Biol 1992; 119: 1309-25.
17. Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC,. An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999; 18: 4440-9. (Pubitemid 29396652)
18. Nakahara H, Mueller SC, Nomizu M, Yamada Y, Yeh Y, Chen WT,. Activation of β1 integrin signaling stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protrusive activities at invadopodia. J Biol Chem 1998; 273: 9-12. (Pubitemid 28042166)
19. Linder S,. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 2007; 17: 107-17. (Pubitemid 46341826)
20. Furmaniak-Kazmierczak E, Crawley SW, Carter RL, Maurice DH, Cote GP,. Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells. Circ Res 2007; 100: 1328-36. (Pubitemid 46742923)
21. Aga M, Bradley JM, Keller KE, Kelley MJ, Acott TS,. Specialized podosome- or invadopodia-like structures (PILS) for focal trabecular meshwork extracellular matrix turnover. Invest Ophthalmol Vis Sci 2008; 49: 5353-65.
22. Buccione R, Caldieri G, Ayala I,. Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev 2009; 28: 137-49.
23. Brown MT, Cooper JA,. Regulation, substrates and functions of Src. Biochim Biophys Acta 1996; 1287: 121-49. (Pubitemid 26189191)
24. Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, et al. Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 1999; 21: 187-90. (Pubitemid 29070364)
25. Talamonti MS, Roh MS, Curley SA, Gallick GE,. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest 1993; 91: 53-60. (Pubitemid 23037252)
26. Muthuswamy SK, Muller WJ,. Activation of the Src family of tyrosine kinases in mammary tumorigenesis. Adv Cancer Res 1994; 64: 111-23. (Pubitemid 24351295)
27. Luxenburg C, Parsons JT, Addadi L, Geiger B,. Involvement of the Src-cortactin pathway in podosome formation and turnover during polarization of cultured osteoclasts. J Cell Sci 2006; 119: 4878-88. (Pubitemid 46017801)
28. Takayanagi H, Juji T, Miyazaki T, Iizuka H, Takahashi T, Isshiki M, et al. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. J Clin Invest 1999; 104: 137-46.
29. Pala D, Kapoor M, Woods A, Kennedy L, Liu S, Chen S, et al. Focal adhesion kinase/Src suppresses early chondrogenesis: central role of CCN2. J Biol Chem 2008; 283: 9239-47.
30. Bursell L, Woods A, James CG, Pala D, Leask A, Beier F,. Src kinase inhibition promotes the chondrocyte phenotype. Arthritis Res Ther 2007; 9: R105.
31. Charbonneau M, Harper K, Grondin F, Pelmus M, McDonald PP, Dubois CM,. Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor α-induced increases in tumor necrosis factor-α converting enzyme/ADAM17 expression by synovial cells. J Biol Chem 2007; 282: 33714-24. (Pubitemid 350159521)
32. Baldassarre M, Ayala I, Beznoussenko G, Giacchetti G, Machesky LM, Luini A, et al. Actin dynamics at sites of extracellular matrix degradation. Eur J Cell Biol 2006; 85: 1217-31. (Pubitemid 44780616)
33. Tolboom TC, Huizinga TW,. In vitro Matrigel fibroblast invasion assay. Methods Mol Med 2007; 135: 413-21.
34. Ritchlin C, Dwyer E, Bucala R, Winchester R,. Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitis. Scand J Immunol 1994; 40: 292-8. (Pubitemid 24272136)
35. Poincloux R, Lizarraga F, Chavrier P,. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J Cell Sci 2009; 122: 3015-24.
36. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor: study of Lck- and FynT-dependent T cell activation. J Biol Chem 1996; 271: 695-701.
37. Wolf K, Friedl P,. Functional imaging of pericellular proteolysis in cancer cell invasion. Biochimie 2005; 87: 315-20. (Pubitemid 40387610)
38. Green MJ, Gough AK, Devlin J, Smith J, Astin P, Taylor D, et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2003; 42: 83-8. (Pubitemid 36131572)
39. Soto H, Hevezi P, Roth RB, Pahuja A, Alleva D, Acosta HM, et al. Gene array analysis comparison between rat collagen-induced arthritis and human rheumatoid arthritis. Scand J Immunol 2008; 68: 43-57. (Pubitemid 351798401)
40. Chin JR, Murphy G, Werb Z,. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase: biosynthesis, isolation, characterization, and substrates. J Biol Chem 1985; 260: 12367-76. (Pubitemid 16228414)
41. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G,. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 1544-50. (Pubitemid 26028643)
42. Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A, et al. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 1997; 40: 1391-9. (Pubitemid 27430949)
43. Bauer S, Jendro MC, Wadle A, Kleber S, Stenner F, Dinser R, et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther 2006; 8: R171.
44. Milner JM, Kevorkian L, Young DA, Jones D, Wait R, Donell ST, et al. Fibroblast activation protein α is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis. Arthritis Res Ther 2006; 8: R23.
45. Ospelt C, Mertens JC, Jungel A, Brentano F, Maciejewska-Rodriguez H, Huber LC, et al. Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2010; 62: 1224-35.
46. Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, Mueller SC, et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 1994; 54: 5702-10. (Pubitemid 24346270)
47. Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM, et al. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res 2006; 312: 1240-53.
48. Defilippi P, Di Stefano P, Cabodi S,. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 2006; 16: 257-63. (Pubitemid 43728873)
49. Nakahara H, Otani T, Sasaki T, Miura Y, Takai Y, Kogo M,. Involvement of Cdc42 and rac small G proteins in invadopodia formation of RPMI7951 cells. Genes Cells 2003; 8: 1019-27. (Pubitemid 38072277)
50. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al, for the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000; 343: 1594-602. (Pubitemid 32162982)